Skip to content
Yahoo Finance's Jared Blikre breaks down some of the features of the Yahoo Finance Premium package....
How markets will respond to the remainder of 2020...
Shares of vaccine maker Moderna (MRNA), a $26.5 billion company that lost half a billion dollars over the past year on sales of barely $50 million, are up more than four times from the $18-and-change price they sold for back at the beginning of the coronavirus crisis five months ago. And profits or no profits, they're likely to go up a lot more today because of an announcement Moderna made after close of trading Tuesday.Releasing an "interim analysis" of the results from a Phase 1 study of its mRNA-1273 vaccine against COVID-19 Tuesday evening, Moderna confirmed that the results now appear to be fully as good as they appeared to be when preliminarily released two months ago."Neutralizing antibody titers were observed in 100% of evaluated participants" regardless of whether they were given 250, 100, or only 25 micrograms (µg). The vaccine was found to be "generally safe and well-tolerated" among patients...
In this article we are going to estimate the intrinsic value of Live Nation Entertainment, Inc. (NYSE:LYV) by taking......
If you want to know who really controls VBI Vaccines Inc. (NASDAQ:VBIV), then you'll have to look at the makeup of its......
